Physician profile
Phillip M Ecker
NPI 1851378020
$31,291.62
in general payments reported to CMS, 2019-2025
24 companies · $61.39 in 2025
The $61.39 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $5,963 · 2021: $291 · 2022: $77.19 · 2024: $70.63 · 2025: $61.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $23,070.51 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $6,671.34 | 2019-2020 | |
| Janssen Biotech, INC. | $842.22 | 2020-2021 | |
| Genzyme Corporation | $106.35 | 2019-2025 | |
| Amgen INC. | $77.73 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $76.88 | 2019-2021 | |
| Ucb, INC. | $66.83 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $44.92 | 2021-2024 | |
| Abbvie INC. | $43.93 | 2019-2020 | |
| Biofrontera INC. | $36.15 | 2020-2021 | |
| Pfizer INC. | $25.53 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $25.00 | 2021 | |
| Mallinckrodt Enterprises LLC | $22.24 | 2019 | |
| Arcutis Biotherapeutics, INC. | $21.99 | 2025 | Zoryve |
| Sensus Healthcare, INC. | $21.34 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Strata Skin Sciences, INC. | $20.68 | 2024 | Xtrac |
| Glaxosmithkline, LLC. | $19.95 | 2021 | |
| Genentech USA, INC. | $18.69 | 2021 | |
| Celgene Corporation | $17.49 | 2019 | |
| Galderma Laboratories, L.P. | $13.20 | 2019 | |
| Dermira, INC. | $12.83 | 2020 | |
| Promius Pharma LLC | $12.09 | 2019 | |
| Kerecis Limited | $12.01 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Leo Pharma INC. | $11.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Ecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.